Smooth muscle cell specific NEMO deficiency inhibits atherosclerosis in ApoE


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 07 2022
Historique:
received: 23 05 2022
accepted: 14 07 2022
entrez: 22 7 2022
pubmed: 23 7 2022
medline: 27 7 2022
Statut: epublish

Résumé

The development of atherosclerotic plaques is the result of a chronic inflammatory response coordinated by stromal and immune cellular components of the vascular wall. While endothelial cells and leukocytes are well-recognised mediators of inflammation in atherosclerosis, the role of smooth muscle cells (SMCs) remains incompletely understood. Here we aimed to address the role of canonical NF-κB signalling in SMCs in the development of atherosclerosis. We investigated the role of NF-κB signalling in SMCs in atherosclerosis by employing SMC-specific ablation of NEMO, an IKK complex subunit that is essential for canonical NF-κB activation, in ApoE

Identifiants

pubmed: 35869246
doi: 10.1038/s41598-022-16737-8
pii: 10.1038/s41598-022-16737-8
pmc: PMC9307802
doi:

Substances chimiques

Apoe protein, mouse 0
Apolipoproteins E 0
Intracellular Signaling Peptides and Proteins 0
NEMO protein, mouse 0
NF-kappa B 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12538

Informations de copyright

© 2022. The Author(s).

Références

Arterioscler Thromb. 1994 Jul;14(7):1032-9
pubmed: 8018657
J Biol Chem. 2005 Jun 10;280(23):22454-61
pubmed: 15797857
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2458-66
pubmed: 20930169
Circulation. 2020 Nov 24;142(21):2060-2075
pubmed: 32962412
Nat Rev Immunol. 2010 Jan;10(1):36-46
pubmed: 19960040
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
Nat Rev Cardiol. 2019 Dec;16(12):727-744
pubmed: 31243391
Circ Res. 2019 Aug 30;125(6):590-605
pubmed: 31318658
J Clin Invest. 2003 Oct;112(8):1176-85
pubmed: 14561702
Nat Med. 2015 Jun;21(6):628-37
pubmed: 25985364
J Cardiovasc Pharmacol. 1997 Mar;29(3):323-30
pubmed: 9125669
Mol Cell Biochem. 2010 Jul;340(1-2):55-62
pubmed: 20157765
Genes Dev. 2012 Feb 1;26(3):203-34
pubmed: 22302935
J Cell Physiol. 2011 Aug;226(8):2103-14
pubmed: 21520062
Nat Immunol. 2010 Feb;11(2):155-61
pubmed: 20037584
J Pharmacol Sci. 2009 Aug;110(4):437-44
pubmed: 19602845
Circ Res. 2006 Mar 31;98(6):785-92
pubmed: 16527993
Annu Rev Immunol. 2009;27:165-97
pubmed: 19302038
J Clin Invest. 2013 Jan;123(1):179-88
pubmed: 23257360
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2045-51
pubmed: 22895665
Cell Metab. 2008 Nov;8(5):372-83
pubmed: 19046569
J Mol Cell Cardiol. 2009 Mar;46(3):431-41
pubmed: 19010332
PLoS One. 2011;6(6):e21055
pubmed: 21695272
Immunol Rev. 2017 May;277(1):113-127
pubmed: 28462531
Circ Res. 2016 Feb 19;118(4):692-702
pubmed: 26892967
J Lipid Res. 1995 Nov;36(11):2320-8
pubmed: 8656070
PLoS One. 2014 Apr 22;9(4):e95935
pubmed: 24755612
Mol Cell. 2000 Jun;5(6):981-92
pubmed: 10911992
J Clin Invest. 1998 Apr 15;101(8):1717-25
pubmed: 9541503
Circulation. 2021 Jan 12;143(2):163-177
pubmed: 33222501
Nat Med. 2008 Jan;14(1):64-8
pubmed: 18084302
Sci Rep. 2017 Dec 4;7(1):16878
pubmed: 29203879
Curr Vasc Pharmacol. 2010 Mar;8(2):285-92
pubmed: 19485909
J Exp Med. 2014 May 5;211(5):869-86
pubmed: 24799533
Nature. 2021 Apr;592(7855):524-533
pubmed: 33883728
Circulation. 2012 Oct 2;126(14):1739-51
pubmed: 22935568
Int J Mol Med. 2014 May;33(5):1341-7
pubmed: 24590381
Nephrol Dial Transplant. 2001;16 Suppl 1:27-33
pubmed: 11369817
J Mol Cell Cardiol. 2014 Jan;66:72-82
pubmed: 24239845
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):1909-14
pubmed: 11742863
Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4489-94
pubmed: 11904364
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1960-9
pubmed: 22652603
Science. 1992 Oct 16;258(5081):468-71
pubmed: 1411543
Cardiovasc Res. 2012 Jul 15;95(2):156-64
pubmed: 22406749
Circulation. 2016 Jun 7;133(23):2263-78
pubmed: 27154724
Arterioscler Thromb Vasc Biol. 2019 May;39(5):876-887
pubmed: 30786740
J Biol Chem. 1997 Jun 20;272(25):15817-24
pubmed: 9188479

Auteurs

Takashi Imai (T)

Institute for Genetics, University of Cologne, 50931, Cologne, Germany.
Centre for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany.

Trieu-My Van (TM)

Institute for Genetics, University of Cologne, 50931, Cologne, Germany.
Centre for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany.

Manolis Pasparakis (M)

Institute for Genetics, University of Cologne, 50931, Cologne, Germany. pasparakis@uni-koeln.de.
Centre for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany. pasparakis@uni-koeln.de.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany. pasparakis@uni-koeln.de.
CECAD Research Center, Institute for Genetics, University of Cologne, Joseph-Stelzmann-Str. 26, 50931, Cologne, Germany. pasparakis@uni-koeln.de.

Apostolos Polykratis (A)

Institute for Genetics, University of Cologne, 50931, Cologne, Germany.
Centre for Molecular Medicine Cologne (CMMC), University of Cologne, 50931, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, 50931, Cologne, Germany.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH